An ascending tendency of lung involvement in TN and HER2 subtype breast cancer was noted in previous studies, with a recorded incidence of 20.8–35.0% and 22.9–45.0%, respectively12–14. The gene discussed is ERBB2; the disease is breast carcinoma.